Myles D. Greenberg

Myles D. Greenberg

Vorstandsvorsitzender bei Alucent Biomedical Inc.

56 Jahre
Health Technology
Consumer Services
Finance

Profil

Myles D.
Greenberg
is currently the President, Chief Executive Officer & Director at Alucent Biomedical Inc. He is also a Director at Urgent Care Centers of New England, Inc. Additionally, he is a Partner at CHL Healthcare Partners LLC since 2013 and a Venture Partner at Healthinvest Equity Partners.
In his former positions, Dr. Greenberg served as the Chairman of Cantex Pharmaceuticals, Inc. He was also a Director at Oriel Therapeutics, Inc., Angiomics, Inc., Millennium Pharmacy Systems, Inc., NuVasive, Inc., Dynogen Pharmaceuticals, Inc., Mevion Medical Systems, Inc., Vertos Medical, Inc., Ivrea Pharmaceuticals, Inc., Oculir, Inc., DICOM Grid, Inc., FlowCardia, Inc., and Assistant Clinical Director-Emergency Department at Beth Israel Deaconess Medical Center, Inc. He held the position of Assistant Clinical Director-Emergency Medicine at Harvard Medical School.
From 2000 to 2004, he was a Senior Principal at Pappas Capital LLC.
He also served as an Assistant Professor at UNC School of Medicine.
Dr. Greenberg's education includes an MBA from Harvard Business School in 2000, a doctorate from Yale School of Medicine in 1993, and an undergraduate degree from the School of Engineering & Applied Science in 1989.

Aktive Positionen von Myles D. Greenberg

UnternehmenPositionBeginn
Private Equity Investor 01.01.2004
Direktor/Vorstandsmitglied -
Private Equity Investor -
Vorstandsvorsitzender -
Alle aktiven Positionen von Myles D. Greenberg

Ehemalige bekannte Positionen von Myles D. Greenberg

UnternehmenPositionEnde
Direktor/Vorstandsmitglied 23.10.2008
Corporate Officer/Principal 31.12.2003
Angiomics, Inc. Direktor/Vorstandsmitglied -
NUVASIVE, INC. Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Sehen Sie sich die Erfahrung von Myles D. Greenberg im Detail an

Ausbildung von Myles D. Greenberg

Harvard Business School Masters Business Admin
Yale School of Medicine Doctorate Degree
School of Engineering & Applied Science Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Myles D. Greenberg im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

23

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen18

Health Technology

Angiomics, Inc.

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Finance

Finance

Health Services

Health Technology

Health Services

Finance

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Myles D. Greenberg